Economic Evaluation of Healthcare Innovation Projects
Startup Vision: From Valuation to Investment
Why this program?:
Healthcare innovation needs to demonstrate value
Economic aspects are now a decisive factor in the development, financing, commercialization and adoption of new healthcare technologies: pharmaceuticals, medical devices, digital solutions and healthcare innovation projects.
From the conceptualization of an idea to its arrival on the market or its incorporation into clinical practice, the economic perspective shapes every key decision: initial funding, evidence generation, value demonstration, access strategy, procurement, pricing and sustainability.
Healthcare innovation is advancing at an increasingly rapid pace. Industry needs to prioritize projects, demonstrate outcomes and communicate value rigorously. At the same time, healthcare systems face growing pressure to incorporate new solutions while maximizing benefits for patients and society in a context of limited resources.
In this scenario, understanding the language of health economics has become an essential capability for all stakeholders involved in the development, evaluation, financing, purchasing, prescription, management or adoption of healthcare technologies.
What does the program provide?:
Practical training to evaluate, finance and defend healthcare innovation
This program offers a comprehensive, practical and up-to-date view of the development and adoption cycle of healthcare technologies.
Throughout the program, participants will acquire the skills needed to analyze the clinical and economic impact of an innovation, build and communicate its value proposition, assess its viability, defend its financing and facilitate its incorporation into the market or into healthcare practice.
The program is aimed at healthcare professionals involved in innovation, decision-making or evaluation processes: clinicians, healthcare managers, researchers, entrepreneurs, professionals from the pharmaceutical, medtech and digital health industries, as well as patient representatives and other stakeholders involved in the transformation of the healthcare system.
What will you achieve?
By the end, you will be able to:
Introduction to health technology assessment
Cost identification and evaluation
Identification and evaluation of clinical benefit
Design, implementation and monitoring
Economic evaluation models
Budget impact and financing
Market access, pricing and reimbursement
Business Case for healthcare innovation
Current trends: European regulation, AI in healthcare and new healthcare policies
Final project / integrative case
Participant Profile
Professionals involved in the development, evaluation, financing, adoption or commercialization of healthcare technologies who need to understand their clinical, economic and financial value. Recommended profiles: - Entrepreneurs and researchers. - Clinical professionals. - Healthcare managers. - Professionals from the pharmaceutical, medtech and digital health industries. - Market Access, Business Development, Innovation and Pricing profiles. I- nvestors and financial profiles. - Licensing and technology transfer professionals.
Requirements
No specific prior training in health economics is required, although it is advisable to have general knowledge of the healthcare sector or professional experience linked to healthcare, innovation, management, industry or project financing.
Aprende de un cuadro docente formado por profesionales en activo
Albert Canela brings over 20 years of experience to the intersection of healthcare innovation, business strategy, market access, and healthcare system sustainability. He has built a distinguished career at leading global companies such as Roche and Bayer, as well as in strategic consulting for pharmaceutical, medtech, and healthcare organizations.
Currently, he serves as a Partner at Alira Health, where he leads global projects focused on strategy, market access, evidence generation, economic evaluation, and the adoption of healthcare innovation. His expertise bridges a strategic vision of the health sector with practical knowledge of the processes required to move an innovation from early-stage development to market entry and clinical practice.
As the Academic Director of this Executive Program at Barcelona Finance School, Albert provides a perspective perfectly aligned with the program’s mission: transforming economic and financial knowledge into practical tools for evaluating, financing, communicating, and defending the value of healthcare innovation projects.
Albert holds an MBA from IESE Business School and a Master’s in Health Economics and Pharmacoeconomics from UPF Barcelona School of Management.
Areas of Specialization:
– Market Access & Pharmacoeconomics
– Economic Evaluation & Budget Impact Analysis
– Evidence Generation & Value-Based Payment Models
– Digital Health & AI Applications in Healthcare
– Business Development in Complex Healthcare Environments
Over 30 years leading financial education
Learnability
We promote, facilitate, and enhance your ability to learn quickly and effectively. We adapt to new situations and maintain a continuous improvement mindset.
Employability
We develop the skills and competencies to obtain, maintain, and enhance your professional profile in a competitive and ever-changing market
Glocality
We combine global and local perspectives in a more connected environment to foster collaboration and commitment in solving challenges.
A curriculum to deepen your understanding of the financial-healthcare field
Live Streaming Sessions
- Live Streaming Sessions
- Applied theory
- Practical Cases
1. Definition and basic concepts. Development phases of health technologies. HTA models (early assessment, national/regional/hospital HTA). Organizational impact (5 hours)
2. Early assessment and defining the Population, Intervention, Comparator, and Outcomes (PICOs) in startups (5 hours)
3. Common methodologies and approaches (5 hours)
4. Case studies and practical applications (5 hours)
1. Types of costs from a financial perspective (fixed, variable, direct, indirect) (3 hours)
2. Types of costs from a health economics perspective (direct healthcare, direct non-healthcare, indirect, and intangible costs) (3 hours)
3. Tools for evaluating and capturing costs according to perspective (4 hours)
Practical cases and examples of cost assessment (2 hours)
1. Types of studies (clinical trials, observational studies, others) and levels of evidence (4 hours)
2. Methods for quantifying clinical benefits (3 hours)
3. Case studies and examples of benefit assessment (3 hours)
1. Study design. Identification of the most relevant potential indicators (endpoints, surrogates, etc.) (2 hours)
2. Drafting protocols and monitoring systems (2 hours)
3. Ongoing adjustments and reassessments throughout development (1 hour)
4. Case studies and examples of study design (2 hours)
- Types of economic evaluations (1 hour)
- Early modeling (Headroom analysis) and price discovery (3 hours)
- Budget impact modeling, Net Present Value (NPV), and Internal Rate of Return (IRR) of the health technology (3 hours)
- Sensitivity analysis and scenario modeling (1 hour)
- Case studies and examples of economic evaluation (2 hours)
1. Decision trees: theory and case study (5 hours)
2. Markov models: theory and case study (10 hours)
3. Other types of models: theory and case study (5 hours)
4. Practical case on identifying the appropriate model (2 hours)
1. How to prepare a health technology assessment report including economic evaluation (2 hours)
2. Effective presentation formats (2 hours)
3. Communicating results to stakeholders, including licensees (1 hour)
